• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用溴化潘库溴铵的二丁酸类似物对血浆胆碱酯酶变体的差异抑制作用。

Differential inhibition of plasma cholinesterase variants using the dibutyrate analogue of pancuronium bromide.

作者信息

Whittaker M, Britten J J

出版信息

Hum Hered. 1981;31(4):242-7. doi: 10.1159/000153216.

DOI:10.1159/000153216
PMID:7287015
Abstract

A steroid, the dibutyrate analogue of pancuronium bromide (9.8 X 10(-8)M), has been used as differential inhibitor in the study of the plasma cholinesterase variants. Pancuronium dibutyrate numbers have been measured for 190 individuals, and the mean values for six of the known genotypes, E1uE1u, E1uE1f, E1uE1a, E1fE1a, E1aE1a, and E1fE1f, have been calculated. Evidence is presented that a combination of the pancuronium dibutyrate number and the fluoride number give better resolution of the six genotypes than the combination of the pancuronium dibutyrate and the dibucaine number. This new differential inhibitor has real potential for revealing the probable existence of new genotypes.

摘要

一种类固醇,即溴化潘库溴铵的二丁酸类似物(9.8×10⁻⁸M),已被用作研究血浆胆碱酯酶变体的差异抑制剂。已对190名个体测定了二丁酸潘库溴铵数值,并计算了六种已知基因型E1uE1u、E1uE1f、E1uE1a、E1fE1a、E1aE1a和E1fE1f的平均值。有证据表明,与二丁酸潘库溴铵和丁卡因数值的组合相比,二丁酸潘库溴铵数值与氟化物数值的组合能更好地分辨这六种基因型。这种新型差异抑制剂在揭示可能存在的新基因型方面具有实际潜力。

相似文献

1
Differential inhibition of plasma cholinesterase variants using the dibutyrate analogue of pancuronium bromide.使用溴化潘库溴铵的二丁酸类似物对血浆胆碱酯酶变体的差异抑制作用。
Hum Hered. 1981;31(4):242-7. doi: 10.1159/000153216.
2
Inhibition of the plasma cholinesterase variants by pancuronium bromide and some of its analogues.泮库溴铵及其一些类似物对血浆胆碱酯酶变体的抑制作用。
Clin Chim Acta. 1980 Nov 20;108(1):89-94. doi: 10.1016/0009-8981(80)90296-x.
3
Inhibition of the plasma cholinesterase variants by propranolol.
Br J Anaesth. 1981 May;53(5):511-6. doi: 10.1093/bja/53.5.511.
4
A comparison of some methods of phenotyping the plasma cholinesterase variants using benzoylcholine as substrate.
Ann Clin Biochem. 1981 Jan;18(Pt 1):9-14. doi: 10.1177/000456328101800103.
5
Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.在血浆胆碱酯酶基因正常和非典型的杂合子患者中,在给予琥珀酰胆碱之前用泮库溴铵进行预处理。
Acta Anaesthesiol Scand. 1991 Aug;35(6):502-7. doi: 10.1111/j.1399-6576.1991.tb03337.x.
6
The inhibition of cholinesterases by pancuronium.
Br J Anaesth. 1975 Sep;47(9):949-54. doi: 10.1093/bja/47.9.949.
7
Cholinesterase inhibition by vecuronium and pancuronium in human airways.维库溴铵和泮库溴铵对人呼吸道胆碱酯酶的抑制作用。
Life Sci. 1994;55(14):PL261-6. doi: 10.1016/0024-3205(94)00248-7.
8
[Inhibition of plasma cholinesterase by pancuronium and vecuronium].[泮库溴铵和维库溴铵对血浆胆碱酯酶的抑制作用]
Lijec Vjesn. 1990 May-Jun;112(5-6):142-3.
9
Succinylcholine neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase.
Anesthesiology. 1981 Sep;55(3):231-5. doi: 10.1097/00000542-198109000-00008.
10
Plasma cholinesterase variants. Family studies of the E1k gene.
Hum Hered. 1985;35(6):364-8. doi: 10.1159/000153581.

引用本文的文献

1
Arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum.人血清中芳基酯酶活性与胆碱酯酶比活性之间的芳基酯酶表型特异性正相关。
Int J Environ Res Public Health. 2014 Jan 27;11(2):1422-43. doi: 10.3390/ijerph110201422.